※一部利用できない機能があります
S1P2, the G protein-coupled receptor for sphingosine-1- phosphate, negatively regulates tumor angiogenesis and tumor growth in vivo in mice
- フォーマット:
- 論文
- 責任表示:
- Du, Wa ; Takuwa, Noriko ; Yoshioka, Kazuaki ; Okamoto, Yasuo ; Gonda, Koichi ; Sugihara, Kazushi ; Fukamizu, Akiyoshi ; Asano, Masahide ; Takuwa, Yoh
- 言語:
- 英語
- 出版情報:
- American Association for Cancer Research, 2010-01-15
- 著者名:
Du, Wa Takuwa, Noriko Yoshioka, Kazuaki Okamoto, Yasuo Gonda, Koichi Sugihara, Kazushi Fukamizu, Akiyoshi Asano, Masahide Takuwa, Yoh - 掲載情報:
- Cancer Research
- ISSN:
- 0008-5472
- 巻:
- 70
- 通号:
- 2
- 開始ページ:
- 772
- 終了ページ:
- 781
- バージョン:
- author
- 概要:
- 金沢大学医薬保健研究域医学系<br />Sphingosine-1-phosphate (S1P) has been implicated in tumor angiogenesis by acting through the Gi-coupled chemotactic receptor S1P1. Here, we report that the distinct receptor S1P2 is responsible for mediating the G … 12/13/Rho-dependent inhibitory effects of S1P on Akt, Rac, and cell migration, thereby negatively regulating tumor angiogenesis and tumor growth. By using S1P2LacZ/+ mice, we found that S1P2 was expressed in both tumor and normal blood vessels in many organs, in both endothelial cells (EC) and vascular smooth muscle cells, as well as in tumor-associated, CD11b-positive bone marrow-derived cells (BMDC). Lewis lung carcinoma or B16 melanoma cells implanted in S1P2-deficient (S1P2-/-) mice displayed accelerated tumor growth and angiogenesis with enhanced association of vascular smooth muscle cells and pericytes. S1P2-/- ECs exhibited enhanced Rac activity, Akt phosphorylation, cell migration, proliferation, and tube formation in vitro. Coinjection of S1P2-/- ECs and tumor cells into wild-type mice also produced a relative enhancement of tumor growth and angiogenesis in vivo. S1P2-/- mice were also more efficient at recruiting CD11b-positive BMDCs into tumors compared with wild-type siblings. Bone marrow chimera experiments revealed that S1P2 acted in BMDCs to promote tumor growth and angiogenesis. Our results indicate that, in contrast to endothelial S1P1, which stimulates tumor angiogenesis, S1P 2 on ECs and BMDCs mediates a potent inhibition of tumor angiogenesis, suggesting a novel therapeutic tactic for anticancer treatment. ©2010 AACR. 続きを見る
- URL:
- http://hdl.handle.net/2297/21765
類似資料:
American Society for Clinical Investigation | |
International Union of Biochemistry and Molecular Biology, Inc / Wiley-Blackwell |
Nature Publishing Group |
International Union of Biochemistry and Molecular Biology, Inc. / Wiley-Blackwell |
Public Library of Science |
American Society for Biochemistry and Molecular Biology |